SCHEMBL26592006

SCHEMBL26592006

N#Cc1ccccc1-c1cccc(-c2nc(-c3ccc4cc(-c5ccccc5)ccc4c3)nc(-c3cc(-c4ccccc4)ccc3-c3ccccc3)n2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.45
▸ ABL1 P00519 1/20 0.43
▸ ESR2 Q92731 1/20 0.42
▸ GABRG2 P18507 6/20 0.41
▸ GABRB3 P28472 6/20 0.41
▸ GABRA5 P31644 4/20 0.41
▸ GABRA3 P34903 4/20 0.41
▸ GABRA1 P14867 5/20 0.41
▸ GABRA2 P47869 4/20 0.41
▸ NR3C1 P04150 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ GRM5 P41594 1/20 0.38
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ USP30 Q70CQ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26592009 0.98 TRPA1 (0.43) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL26591999 0.96 TRPA1 (0.43) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL26592004 0.96 TRPA1 (0.43) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL26592014 0.96 TRPA1 (0.46) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL26591997 0.95 TRPA1 (0.43) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL27368560 0.95 ESR2 (0.44) TRPA1ESR2GABRG2GABRB3GABRA5
SCHEMBL26592002 0.95 ESR2 (0.44) TRPA1ESR2GABRG2GABRB3GABRA5
SCHEMBL26591983 0.93 TRPA1 (0.45) TRPA1ABL1ESR2GABRG2GABRB3
SCHEMBL27368552 0.91 ESR2 (0.43) TRPA1ESR2GABRG2GABRB3GABRA5
SCHEMBL27368467 0.90 ESR2 (0.44) TRPA1ESR2GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR TRPA1 50/4885ABL1 2449/4885ESR2 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback